1Richardson P, Hideshima T, Anderson K. Thalidomide: emerging role in cancer medicine [J]. Ann Rev Med, 2002, 53 (4) : 629-657. 被引量：1
2Aristotle B and Meletios AD. Angiogenesis in human cancer: implications in cancer therapy [J]. European Journal of Internal Medicine, 2003, 14 (8) : 459-469. 被引量：1
3Lukits J, Timar J,Juhasz A. Progression difference between cancers, of the larynx and hypopharynx is not due to tumor size and vascularization[J]. Otolaryngology-Head and Neck Surgery, 2001, 125 (1): 18-22. 被引量：1
4Keyhani A,Jendiroba DB,Freireich EJ. Angiogenesis and leukemia [J]. Leuk Res Leukemia Research, 2001,25 (8) : 639-645. 被引量：1
5Stepien HM, Kolomeeki K,Pasieka Z. Angiogenesis of endocrine gland tumors-new molecular targets in diagnostics and therapy [J]. European Journal of Endocrinology, 2002, 146 (2) : 143-151. 被引量：1
6Folkman J. What is the role of thymidine phosphorylase in tumor angiogenesis[J]. JNCI Journal of the National Cancer Institute, 1996, 88 (16): 1091-1092. 被引量：1
8Kotoh T, Dhar DK, Masunaga R. Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice[J]. Surgery, 1999, 125 (5) : 536-544. 被引量：1
9Steins MBT, Bieker R. Efficacy and safety of thalidomide in patients with acute myeloid leukemia [J]. Blood, 2002,99 (3):834-839. 被引量：1
10Stephens TD, Bunde CJ, Fillmore BJ. Mechanism of action in thalidomide teratogenesis [J]. Biochem Pharmacol, 2000,59 (12): 1489- 1499. 被引量：1
